Pharmafile Logo
Pharmafocus logo
Advanced Search
jj_sign_on_wall

J&J to reveal drug price increases next month

January 16, 2017
Sales and Marketing Johnson & Johnson

Next month, Johnson & Johnson will reveal the average price increases of its prescription drugs in a move to increase …

News
novo_nordisk_flag

Novo strikes up personalised diabetes treatment deal with Glooko

January 16, 2017
Sales and Marketing Glooko, Novo Nordisk, ibm

Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with …

News
mr058666-web

Merck in $230 million swoop for Vertex cancer programmes

January 16, 2017
Sales and Marketing Vertex

Merck has completed a deal with Boston-based biotech firm Vertex Pharmaceuticals for the rights to four cancer programmes worth $230 …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

News
mauriciof-269

Advancing the Pharmaceutical Supply Chain

January 13, 2017
Manufacturing and Production, Medical Communications Janssen, batch manufacturing, continuous manufacturing

Mauricio Futran, vice president, Process Sciences, Janssen Supply Chain, discusses, in the latest issue of Pharmafile, Janssen’s move into continuous …

News
lillycorporatehq

Lilly three strikes in three years not out in Teva patent challenge

January 13, 2017
Medical Communications, Sales and Marketing Eli Lilly, Teva, generics, lilly, patent

Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …

News

NICE recommends Novartis’ previously CDF-exclusive kidney cancer treatment

January 13, 2017
Medical Communications, Sales and Marketing Afinitor, CDF, NICE, Novartis, everolimus

In a reappraisal decision by NICE, everolimus (Novartis’ Afinitor) has been recommended for the treatment of advanced renal cell carcinoma …

News
wales_flag

Welsh government launches £80 million fund for newly approved drugs

January 13, 2017
Medical Communications Wales, Welsh Government, drug fund

The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …

News
1280px-epi-pen_1

Drugstore chain CVS offers EpiPen generic for 600% cheaper

January 12, 2017
Medical Communications, Sales and Marketing CVS, Mylan, epipen

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …

News

IBM and FDA collaborate to protect patient data with blockchain technology

January 12, 2017
Medical Communications, Research and Development FDA, blockchain, blockchain technology, ibm

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …

News
entrance_takeda_i020_v1

Takeda invests $125m in Maverick T-cell platform partnership

January 12, 2017
Research and Development Maverick, Takeda

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …

News
biocon_office

Mylan and Biocon apply to FDA for biosimilar approval

January 12, 2017
Sales and Marketing Biocon, FDA, Mylan, biosimilar, trastuzumab

Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …

News
shire_image_4

Shire fined $350 million in largest-ever bribery case of its kind

January 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

News

New immunotherapy-based cancer research limits cancer spread by 75%

January 12, 2017
Medical Communications, Research and Development Cancer, cancer research, immunotherapy

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

News
riodejaneiro_aerea_aeroportogaleao-131756cut

Rio De Janeiro’s primary airport awarded CEIV Pharma certification

January 11, 2017
Manufacturing and Production Rio Galeao, cargo

Rio Galeão, the main airport serving Rio De Janeiro, has been awarded Centre of Excellence for Independent Validators (CEIV) Pharma …

News

MSD and Lilly announce immuno-oncology collaboration

January 11, 2017
Medical Communications, Research and Development Eli Lilly, Lartruvo, MSD, keytruda, lilly

MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …

News

MPS extends its range of child resistant packaging

January 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …

News
Press release
merck_and_co

MSD looks to jump the gun with combination immunotherapy application

January 11, 2017
Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …

News
c_agsandrew_-_fotolia

Philips and Illumina partner up for integrated genomics oncology solution

January 11, 2017
Research and Development Illumina, Philips, oncology

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

News
joe_biden_and_obama

New formulary ‘bank’ to aid research into combination therapies

January 11, 2017
Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy

As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026